BC
AVNS

Brinker Capital’s Avanos Medical AVNS Stock Holding History

Brinker Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,724
Closed -$250K – 936
2019
Q2 		$250K Sell
5,724
-274
-5% -$11.7K 0.01% 853
2019
Q1 		$256K Buy
+5,998
New +$269K 0.01% 836
2018
Q4 		– Sell
-4,778
Closed -$327K – 871
2018
Q3 		$327K Sell
4,778
-162
-3% -$10.4K 0.01% 833
2018
Q2 		$283K Buy
+4,940
New +$261K 0.01% 882

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Brinker Capital's AVNS Position: Q3 2019 in Review

Brinker Capital sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 5,724 shares — an estimated $250K sold.

Brinker Capital first reported a position in AVNS in Q2 2018 and held it in 4 quarters. The position peaked at $327K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Brinker Capital reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
  • Brinker Capital sold 5,724 Avanos Medical shares in Q3 2019, an estimated $250K.
  • Brinker Capital first reported a position in Avanos Medical in Q2 2018 and held it in 4 quarters.
  • Brinker Capital's Avanos Medical position peaked at $327K in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Brinker Capital's 13F filing for Q3 2019, filed 21 Oct 2019.